• Home
• Mailbox
• Boards
• Favorites
• Whats Hot!
• Login - Join Now!

Search Search Type Board Post Member

Profile

About Latest Posts Latest Blog Posts Boards Posted On Boards Moderating

chemistfrog's Profile

Avatar:

Membership:

Premium

Person Marks:

3

Total Posts:

2

Total Blog Posts:

0

Total Compensated Posts:

0

Moderating:

1

Alias Born

02/25/2012 10:37:10 PM

Personal info

Recent Articles

• Investors Alert: Legal Investigation into Perpetua Resources
• Exploring the Future of the Polymethyl Methacrylate Market
• UMH Properties Announces First Quarter 2025 Financial Insights
• Investors Urged to Act: Faruqi & Faruqi Investigates TBBK
• Investigation into Everus: What Investors Need to Know Now
• Insights for Solaris Energy Investors on Legal Options Ahead
• Investors Invited to Join TFI International Class Action
• Investors Eye e.l.f. Beauty Amid Legal Investigations
• Investors Stand Strong amid enCore Energy’s Unfolding Issues
• Faruqi & Faruqi Investigates Geron Corporation Securities Claims
• Keurig Dr Pepper Prices Secondary Offering of Shares
• Smart Digital Group Limited Schedules Share Offering
• Investigation into Bakkt Holdings: Understanding the Claims
• First National Bank Alaska Announces Upcoming Cash Dividend
• COFIDE Announces Completion of its Tender Offer for Notes
• Understanding SoundHound AI's Legal Challenges and Investor Rights
• Investors Urged to Take Action on AppLovin Securities Claims
• Fortis Law Partners Announces Key Promotions of Attorneys
• Equinor's Strategic Sale of Peregrino Field: A $3.5 Billion Move
• BTC Digital Ltd. Enhances Operations with New Hosting Agreement
• Investors Urged to Take Action Against BigBear.ai for Losses
• Detroit Amplifiers Welcome Star Coaches for BIG3 Season
• Investors Urged to Connect with Faruqi & Faruqi on Zynex Claims
• Investors May Stand to Gain from NET Power Legal Action
• Opportunity for CGC Investors to Join Securities Class Action
• Understanding Your Rights: Actinium Pharmaceuticals and Investor Losses
• Genmab's Strategic Move Towards FDA Submission for Epcoritamab
• Faircourt Gold Income Corp. Reveals Class A Share Redemption Details
• Brazil Potash Prepares for Key Investor Engagements and Updates
• Final Teams of CIEE UNHCR Challenge Ready to Make Impact
• Investigation into Maravai LifeSciences: Your Rights Explained
• Open Lending Corporation Faces Class Action Investors Alert
• HASA Expands Horizons with Acquisition of Clearwater Chemicals
• Investors Alert: Faruqi & Faruqi Reviews Claims on Ready Capital
• FioBit: Innovating the Future of Cloud Mining for Everyone
• Critical Investor Alert: Skyworks Solutions Needs Attention
• Teleflex Class Action Investigation: Key Details for Investors
• Investors of Ultra Clean Urged to Act Amidst Stock Decline
• Leadership Transition at Huntsman Corporation Announced
• Celebrating International Jazz Day 2025: A Global Music Fest
• Bully Max Excels at American Advertising Awards with Triple Win
• Investors of Ibotta Urged to Seek Legal Guidance Amid Losses
• EQT AB Priced Senior Notes Offer to Enhance Corporate Flexibility
• Investigation of Viatris Investors' Claims With Legal Expertise
• EQT AB (publ) Successfully Prices First Senior Notes Offering
• Centaurus Financial Offers Dynamic Workshop to Support Growth
• Discover the Innovative Features of the 2026 Hyundai IONIQ 9
• Investors Alert: Avis Budget Group Faces Legal Action for Losses
• Landsea Homes to Release Earnings Report for Q1 2025 Soon
• Los Angeles Food Bank Secures $1 Million Grant for Relief Efforts